Introduction Cancer treatment has undergone a dramatic transformation in recent years, moving from broad cytotoxic chemotherapies toward molecularly precise strategies tailored to specific genetic, epigenetic, and proteomic vulnerabilities. The rise of targeted therapies, immuno-oncology, and multimodal approaches has already reshaped clinical practice. Yet, many cancers, particularly those harboring mutations long considered “undruggable”, remain resistant […]
Introduction Cancer treatment has undergone a dramatic transformation in recent years, moving from broad cytotoxic chemotherapies toward molecularly precise strategies tailored to specific genetic, epigenetic, and proteomic vulnerabilities. The
G Protein Coupled Receptors (GPCRs) represent a vast and diverse family of membrane proteins that are central to the regulation of human immune cell function. These receptors mediate responses
Introduction Autoimmune diseases constitute a complex group of disorders in which immune system dysregulation leads to chronic inflammation and tissue damage. Among these diseases, rheumatoid arthritis (RA), inflammatory bowel disease
Flow cytometry stands at the forefront of cancer diagnostics and therapeutics, transforming oncology practice through its capacity to dissect cellular and molecular complexity. By enabling the simultaneous measurement of
Flow cytometry has emerged as a cornerstone technology in clinical trials, providing unparalleled capabilities to probe in depth characteristics of single cells simultaneously through multiparametric analysis. Its application spans
INTRODUCTION Adeno-Associated Virus (AAV) mediated gene therapy is rapidly advancing as new clinidal trials are beginning for the treatment of multiple diseases. As a result there is an increasing
A recent study published in the journal Cell unveils the discovery of vitamin C’s ability to directly modify proteins through a process known as vitcylation. This breakthrough marks a
A groundbreaking study published in Nature by researchers from the Children’s Mercy Research Institute (Kansas) and the University of Kansas Medical Center introduces patient-derived organoid models for evaluating personalized therapeutics.
Antibody-conjugated lipid nanoparticles (LNPs) represent a transformative advancement in targeted drug delivery, combining the specificity of monoclonal antibodies with the versatility of LNPs. These systems have gained significant attention for
With 30+ years of expertise in cell-based potency assay development, we provide accurate, GMP-compliant assays for AAV vectors and gene therapy candidates, ensuring a faster path to clinical success. Click
